Ketamine – a medicine long used as an anesthetic – is finding a powerful new purpose in hospice and palliative care settings.  Dr. Rohini Kanagante, a physician with expertise spanning both Hospice Care and Integrative Psychiatry, unveils the remarkable potential of this medication in our latest episode of TCNtalks.

 Chris Comeaux invites Dr. Rohini Kanniganti, a hospice physician, to delve into the incorporation of ketamine in hospice and palliative care.  They examine the notion of total pain, how ketamine aids in addressing pain and mental health challenges at the end of life, and the practical applications and regulatory factors involved in its use. 

Dr. Kanniganti shares her experiences and insights on how ketamine can offer relief to patients in hospice care, highlighting the significance of meticulous administration and a comprehensive approach to patient care.  They explore the ethical considerations of ketamine use, its potential future acceptance in hospice environments, and the necessity of empowering staff and leaders to improve patient care.  

The conversation highlights the importance of a compassionate approach to end-of-life care, emphasizing the well-being of patients and their families in conjunction with this innovative treatment method.

This is a great listen for your clinical staff and leaders.  Join us - this is a timely and relevant event.

Guest:  Dr. Rohini Kanniganti, MD, MSPH, HMDC, Hospice Physician 

Host:  Chris Comeaux, President / CEO of Teleios Collaborative Network

https://www.teleioscn.org/tcntalkspodcast/breaking-barriers-ketamines-role-in-hospice-medicine-with-dr.-rohini-kanniganti

Teleios Collaborative Network / https://www.teleioscn.org/tcntalkspodcast